Renalytix PLC
LSE:RENX
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.5
50.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Renalytix PLC
Renalytix PLC
Cash & Cash Equivalents
Renalytix PLC
Cash & Cash Equivalents Peer Comparison
CRW
IUG
EMIS
DOC
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Renalytix PLC
LSE:RENX
|
Cash & Cash Equivalents
$24.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
259%
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Cash & Cash Equivalents
$34.6m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Cash & Cash Equivalents
£3m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
EMIS Group PLC
LSE:EMIS
|
Cash & Cash Equivalents
£48.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Cash & Cash Equivalents
£6.1m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
P
|
Physitrack PLC
STO:PTRK
|
Cash & Cash Equivalents
€536k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
See Also
What is Renalytix PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
24.7m
USD
Based on the financial report for Jun 30, 2023, Renalytix PLC's Cash & Cash Equivalents amounts to 24.7m USD.
What is Renalytix PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
259%
Over the last year, the Cash & Cash Equivalents growth was -40%. The average annual Cash & Cash Equivalents growth rates for Renalytix PLC have been 23% over the past three years , 259% over the past five years .
You don't have any saved screeners yet
